These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26421273)

  • 41. [When is a diagnosis of borreliosis advisable?].
    einhard
    Dtsch Med Wochenschr; 2003 Feb; 128(8):399. PubMed ID: 12594629
    [No Abstract]   [Full Text] [Related]  

  • 42. Delineation of species-specific binding properties of the CspZ protein (BBH06) of Lyme disease spirochetes: evidence for new contributions to the pathogenesis of Borrelia spp.
    Rogers EA; Marconi RT
    Infect Immun; 2007 Nov; 75(11):5272-81. PubMed ID: 17846117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RpoS is not central to the general stress response in Borrelia burgdorferi but does control expression of one or more essential virulence determinants.
    Caimano MJ; Eggers CH; Hazlett KR; Radolf JD
    Infect Immun; 2004 Nov; 72(11):6433-45. PubMed ID: 15501774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The plasmids of Borrelia burgdorferi: essential genetic elements of a pathogen.
    Stewart PE; Byram R; Grimm D; Tilly K; Rosa PA
    Plasmid; 2005 Jan; 53(1):1-13. PubMed ID: 15631949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persister Development by Borrelia burgdorferi Populations In Vitro.
    Caskey JR; Embers ME
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6288-95. PubMed ID: 26248368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks.
    Li X; Pal U; Ramamoorthi N; Liu X; Desrosiers DC; Eggers CH; Anderson JF; Radolf JD; Fikrig E
    Mol Microbiol; 2007 Feb; 63(3):694-710. PubMed ID: 17181780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lyme borreliosis--the most frequent vector-borne infection in Denmark].
    Lebech AM; Hansen K
    Ugeskr Laeger; 2004 Jun; 166(25):2431-3. PubMed ID: 15283107
    [No Abstract]   [Full Text] [Related]  

  • 48. Erythromycin resistance in Borrelia burgdorferi.
    Terekhova D; Sartakova ML; Wormser GP; Schwartz I; Cabello FC
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3637-40. PubMed ID: 12384380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular survival strategies of the Lyme disease spirochete Borrelia burgdorferi.
    Singh SK; Girschick HJ
    Lancet Infect Dis; 2004 Sep; 4(9):575-83. PubMed ID: 15336225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?
    Hodzic E
    Bosn J Basic Med Sci; 2015 Jul; 15(3):1-13. PubMed ID: 26295288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flow-Tolerant Adhesion of a Bacterial Pathogen to Human Endothelial Cells Through Interaction With Biglycan.
    Salo J; Pietikäinen A; Söderström M; Auvinen K; Salmi M; Ebady R; Moriarty TJ; Viljanen MK; Hytönen J
    J Infect Dis; 2016 May; 213(10):1623-31. PubMed ID: 26740275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absence of sodA Increases the Levels of Oxidation of Key Metabolic Determinants of Borrelia burgdorferi.
    Esteve-Gassent MD; Smith TC; Small CM; Thomas DP; Seshu J
    PLoS One; 2015; 10(8):e0136707. PubMed ID: 26322513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-tumor necrosis factor-alpha treatment for Lyme borreliosis.
    McSweegan E
    J Infect Dis; 2007 Dec; 196(12):1866; author reply 1866-7. PubMed ID: 18190271
    [No Abstract]   [Full Text] [Related]  

  • 54. Protective value of prophylactic antibiotic treatment of tick bite for Lyme disease prevention: an animal model.
    Piesman J; Hojgaard A
    Ticks Tick Borne Dis; 2012 Jun; 3(3):193-6. PubMed ID: 22421585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular evidence of coinfection of Borrelia burgdorferi sensu lato, human granulocytic ehrlichiosis agent, and Babesia microti in ticks from northwestern Poland.
    Skotarczak B; Rymaszewska A; Wodecka B; Sawczuk M
    J Parasitol; 2003 Feb; 89(1):194-6. PubMed ID: 12659331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The luxS gene is not required for Borrelia burgdorferi tick colonization, transmission to a mammalian host, or induction of disease.
    Blevins JS; Revel AT; Caimano MJ; Yang XF; Richardson JA; Hagman KE; Norgard MV
    Infect Immun; 2004 Aug; 72(8):4864-7. PubMed ID: 15271949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lyme disease: point/counterpoint.
    Stricker RB; Lautin A; Burrascano JJ
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):155-65. PubMed ID: 15918774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The etiological agent of Lyme disease, Borrelia burgdorferi, appears to contain only a few small RNA molecules.
    Ostberg Y; Bunikis I; Bergström S; Johansson J
    J Bacteriol; 2004 Dec; 186(24):8472-7. PubMed ID: 15576797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transposon mutagenesis as an approach to improved understanding of Borrelia pathogenesis and biology.
    Lin T; Troy EB; Hu LT; Gao L; Norris SJ
    Front Cell Infect Microbiol; 2014; 4():63. PubMed ID: 24904839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lyme disease associated with Alzheimer's disease.
    Meer-Scherrer L; Chang Loa C; Adelson ME; Mordechai E; Lobrinus JA; Fallon BA; Tilton RC
    Curr Microbiol; 2006 Apr; 52(4):330-2. PubMed ID: 16528463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.